Foresite Capital Management V as of Dec. 31, 2021
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 16 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 37.8 | $154M | 9.4M | 16.37 | |
| Somalogic Com Cl A | 15.2 | $62M | 5.3M | 11.64 | |
| Theseus Pharmaceuticals | 10.0 | $41M | 3.2M | 12.68 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 4.5 | $18M | 2.3M | 7.87 | |
| Aclaris Therapeutics (ACRS) | 4.5 | $18M | 1.3M | 14.54 | |
| Cullinan Oncology (CGEM) | 4.3 | $18M | 1.1M | 15.43 | |
| Cue Health (HLTHQ) | 3.8 | $16M | 1.2M | 13.41 | |
| Kinnate Biopharma | 3.8 | $16M | 875k | 17.72 | |
| Compass Therapeutics (CMPX) | 3.4 | $14M | 4.4M | 3.17 | |
| Adagio Therapeutics (IVVD) | 3.1 | $13M | 1.7M | 7.26 | |
| Adicet Bio (ACET) | 2.9 | $12M | 680k | 17.49 | |
| Hims & Hers Health Com Cl A (HIMS) | 2.7 | $11M | 1.7M | 6.55 | |
| Gemini Therapeutics | 1.7 | $7.1M | 2.4M | 2.91 | |
| Research Alliance Corp. II Com Cl A | 1.2 | $4.9M | 500k | 9.77 | |
| 23andMe Holding Com Cl A (ME) | 0.7 | $2.7M | 407k | 6.66 | |
| Pharvaris N V (PHVS) | 0.1 | $491k | 34k | 14.38 |
